Insulin Pump Market Scope And Analysis

Report Code : TIPHE100001290
Category : Medical Device

No. of Pages : 150

Buy Now

Insulin Pumps Market Scope and Key Players Analysis by 2031

Buy Now

Insulin Pumps Market Report Scope

Report Attribute	Details
Market size in 2021	US$ 7.81 Billion
Market Size by 2031	US$ 19.08 Billion
Global CAGR (2023 - 2031)	11.80%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Type Tube Pumps Patch Pumps By Product Pumps Accessories By Application Type I Diabetes Type II Diabetes
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Insulet Corporation Medtronic Tandem Diabetes Care Inc Debiotech S A CELLNOVO SOOIL Developments Co Ltd Microport Scientific Corporation Valeritas Inc F Hoffmann La Roche Ltd Ypsomed AG

Insulin Pumps Market News and Recent Developments

The Insulin Pumps Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in them market for Insulin Pumps and strategies:

Switzerland-based PharmaSens applied for FDA approval for its 'niia essential' insulin patch pump system. The company also achieved ISO 13485 certification in November 2023 for the system's design, development, manufacture, and distribution. The product is a basal-bolus patch pump with a streamlined design that combines the ease of an insulin pen with the advantages of a sophisticated insulin pump. It features an innovative 3ml reservoir, making it one of the most compact patch pumps on the market. The insulin patch pump system also incorporates an automatic needle insertion mechanism and a semi-reusable concept for cost-efficiency and sustainable product design. (Source: PharmaSens AG, Press Release, 2023)
The US Food and Drug Administration (FDA) approved the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people aged 6 and above with type 1 diabetes. These two devices and a compatible FDA-cleared integrated continuous glucose monitor (iCGM) form a new system called the iLet Bionic Pancreas. The new automated insulin dosing (AID) system uses an algorithm to determine and command insulin delivery. (Source: US FDA, Press Announcements, 2023)

Insulin Pumps Market Report Coverage and Deliverables

The “Insulin Pumps Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Market dynamics such as drivers, restraints, and key opportunities
Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis
Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
Detailed company profiles